Volume 8, Issue 1 (Feb 2023)
JNFS 2023, 8(1): 83-93 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Kamali Z, Ziaei S, Kazemnejad A, Movahedinejad M. The Relationship between Insulin Resistance and Micronutrient Intake in Polycystic Ovary Syndrome Subgroups. JNFS 2023; 8 (1) :83-93
URL: http://jnfs.ssu.ac.ir/article-1-468-en.html
URL: http://jnfs.ssu.ac.ir/article-1-468-en.html
Department of Midwifery and Reproductive Health, Tarbiat Modares University, Tehran, Iran
Abstract: (904 Views)
Background: Polycystic ovary syndrome (PCOS) is with oxidative stress in women of reproductive age. Oxidative stress is an important factor in the development of insulin resistance. Some micronutrients are also linked to oxidative stress. The aim of this study was to determine the relationship between insulin resistance and micronutrient intake in PCOS subgroups. Methods: This case-control study was performed on 151 PCOS. They were divided into four groups according to the Rotterdam diagnostic criteria: D = 37, C = 40, B = 33,
A = 41 and 31 women were also in the control group and did not have this syndrome. Micronutrient food intake was assessed with a 168-item FFQ feed frequency questionnaire. Insulin resistance was diagnosed with HOMA-IR index (Cut off> 2.5). The data were analyzed with SPSS 22 using Kruskal Wallis (KW), Spearman, and Chi-square tests. Results: The mean age of participants was 28.53 years. There was a significant relationship between the HOMA-IR and some dietary components (selenium depletion in group A, zinc depletion, vitamin D, and vitamin E in group D, and vitamin D and vitamin E depletion in control group)
(P < 0.05). There was no relationship between subgroups B and C. Conclusion: Due to the significant relationship between insulin resistance indices, increasing the dietary intake of zinc, selenium, vitamin D, and vitamin E in women with PCOS, as well as increasing the dietary intake of these micronutrients in improving the physical health and fertility parameters of these people is recommended.
A = 41 and 31 women were also in the control group and did not have this syndrome. Micronutrient food intake was assessed with a 168-item FFQ feed frequency questionnaire. Insulin resistance was diagnosed with HOMA-IR index (Cut off> 2.5). The data were analyzed with SPSS 22 using Kruskal Wallis (KW), Spearman, and Chi-square tests. Results: The mean age of participants was 28.53 years. There was a significant relationship between the HOMA-IR and some dietary components (selenium depletion in group A, zinc depletion, vitamin D, and vitamin E in group D, and vitamin D and vitamin E depletion in control group)
(P < 0.05). There was no relationship between subgroups B and C. Conclusion: Due to the significant relationship between insulin resistance indices, increasing the dietary intake of zinc, selenium, vitamin D, and vitamin E in women with PCOS, as well as increasing the dietary intake of these micronutrients in improving the physical health and fertility parameters of these people is recommended.
Type of article: orginal article |
Subject:
public specific
Received: 2021/08/31 | Published: 2023/02/21 | ePublished: 2023/02/21
Received: 2021/08/31 | Published: 2023/02/21 | ePublished: 2023/02/21
References
1. Amooee S, Parsanezhad ME, Shirazi MR, Alborzi S & Samsami A 2013. Metformin versus chromium picolinate in clomiphene citrate-resistant patients with PCOs: A double-blind randomized clinical trial. Iranian journal of reproductive medicine. 11 (8): 611.
2. Ardabili HR, Gargari BP & Farzadi L 2012. Vitamin D supplementation has no effect on insulin resistance assessment in women with polycystic ovary syndrome and vitamin D deficiency. Nutrition research. 32 (3): 195-201.
3. Asghari G, et al. 2012. Reliability, comparative validity and stability of dietary patterns derived from an FFQ in the Tehran Lipid and Glucose Study. British journal of nutrition. 108 (6): 1109-1117.
4. Berek J & Brerek N 2012. Novak's gynecology, Chapter 35, endocrine disorders.
5. Bikle D 2009. Nonclassic actions of vitamin D. Journal of clinical endocrinology & metabolism. 94 (1): 26-34.
6. Brady C, Mousa S & Mousa S 2009. Polycystic ovary syndrome and its impact on women’s quality of life: More than just an endocrine disorder. Drug, healthcare and patient safety. 1: 9-15.
7. Caballero B 1993. Vitamin E improves the action of insulin. Nutrition reviews. 51 (11): 339-340.
8. Chiu K, Chu A, Go V & Saad M 2004. Hypovitaminosis D is associated with insulin resistance and β cell dysfunction. American journal of clinical nutrition. 79 (5): 820-825.
9. Chung M, et al. 2009. Vitamin D and calcium: a systematic review of health outcomes. Evidence report/technology assessment. 1 (183): 1-42.
10. Dorfman L 2012. Nutrition for Exercise and Sports Performance. In Krause's Food & The Nutrition Care Process (ed. L. Kathleen Mahan).
11. Douglas CC, et al. 2006. Difference in dietary intake between women with polycystic ovary syndrome and healthy controls. Fertility and sterility. 86 (2): 411-417.
12. Foroozanfard F, et al. 2015. Effects of zinc supplementation on markers of insulin resistance and lipid profiles in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Experimental and clinical endocrinology & diabetes. 123 (4): 215-220.
13. Gabrielli L & Aquino E 2012. Polycystic ovary syndrome in Salvador, Brazil: a prevalence study in primary healthcare. Reproductive biology and endocrinology. 10 (1): 1-10.
14. Gol Afroozi M & Koushak A 2006. The Relationship between Carotenoids Received with Blood Glucose and Lipid Indicators in Type II Diabetes Mellitus. Journal of Ardabil University of medical sciences. 3 (6): 287-290.
15. González F, Rote NS, Minium J & Kirwan JP 2006. Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome. Journal of clinical endocrinology & metabolism. 91 (1): 336-340.
16. Goodarzi M, Dumesic D, Chazenbalk G & Aziz R 2011. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nature reviews endocrinology. 7 (4): 219-231.
17. Guler I, et al. 2014. Zinc and homocysteine levels in polycystic ovarian syndrome patients with insulin resistance. Biological trace element research. 158 (3): 297-304.
18. Hahn S, et al. 2006. Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome. Experimental and clinical endocrinology & diabetes. 114 (10): 577-583.
19. Hashemi S, Tehrani F, Noroozzadeh M & Azizi F 2014. Normal cut-off values for hyperandrogenaemia in Iranian women of reproductive age. European journal of obstetrics & gynecology and reproductive biology. 172: 51-55.
20. Hashemipour M, et al. 2009. Effect of zinc supplementation on insulin resistance and components of the metabolic syndrome in prepubertal obese children. Hormones (Athens). 8 (4): 279-285.
21. Hosseini-Esfahani F, et al. 2015. Interaction of APOC3 polymorphism and dietary fats on the risk of metabolic syndrome. Iranian journal of endocrinology and metabolism. 16 (5): 345-355.
22. Hosseinzadeh FM, Hosseinzadeh-Attar MJ, Yekaninejad MS & Rashidi B 2016. Effects of selenium supplementation on glucose homeostasis and free androgen index in women with polycystic ovary syndrome: a randomized, double blinded, placebo controlled clinical trial. Journal of trace elements in medicine and biology. 34: 56-61.
23. Isharwal S, Misra A, Wasir J & Nigam P 2009. Diet & insulin resistance: a review & Asian Indian perspective. Indian journal of medical research. 129 (5): 485-499.
24. Jamilian M, et al. 2016. Effects of zinc supplementation on endocrine outcomes in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Biological trace element research. 170 (2): 271-278.
25. Jamilian M, et al. 2015. Metabolic response to selenium supplementation in women with polycystic ovary syndrome: a randomized, double‐blind, placebo‐controlled trial. Clinical endocrinology. 82 (6): 885-891.
26. Javanmanesh F, Kashanian M, Rahimi M & Sheikhansari N 2016. Comparison between the effects of metformin and N-acetyl cysteine (NAC) on some metabolic and endocrine characteristics of women with polycystic ovary syndrome. Gynecological endocrinology. 32 (4): 285-289.
27. Kar S 2013. Anthropometric, clinical, and metabolic comparisons of the four Rotterdam PCOS phenotypes: A prospective study of PCOS women. Journal of human reproductive sciences. 6 (3): 194-200.
28. Kim HM, Park J, Ryu SY & Kim J 2007. The effect of menopause on the metabolic syndrome among Korean women: the Korean National Health and Nutrition Examination Survey, 2001. Diabetes care. 30 (3): 701-706.
29. Krul-Poel Y, et al. 2018. Vitamin D and metabolic disturbances in polycystic ovary syndrome (PCOS): A cross-sectional study. PloS one. 13 (12): e0204748.
30. Lydic ML, et al. 2006. Chromium picolinate improves insulin sensitivity in obese subjects with polycystic ovary syndrome. Fertility and sterility. 86 (1): 243-246.
31. Manning P, Sutherland W, Walker R & Williams S 2004. Effect of high- dose vitamin E on insulin resistance and associated parameters in overweight subjects. Diabetes care. 27 (9): 2166-2171.
32. March W, et al. 2010. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Human reproduction. 25 (2): 544-551.
33. Marreiro DN, et al. 2004. Participation of zinc in insulin resistance. Arquivos Brasileiros de endocrinologia & metabologia. 48 (2): 234-239.
34. Marshall JC & Dunaif A 2012. Should all women with PCOS be treated for insulin resistance? Fertility and sterility. 97 (1): 18-22.
36. Matthews D, et al. 1985. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 28 (7): 412-419.
37. Mehrabian F, Khani B, Kelishadi R & Kermani N 2011. The prevalence of metabolic syndrome and insulin resistance according to the phenotypic subgroups of polycystic ovary syndrome in a representative sample of Iranian females. Jjournal of Isfahan University of medical sciences. 16 (6): 763-769.
38. Miranda E & Dey C 2004. Effect of chromium and zinc on insulin signaling in skeletal muscle cells. Biological trace element research. 101 (1): 19-36.
39. Mirmiran P, Esfahani FH, Mehrabi Y, Hedayati M & Azizi F 2010. Reliability and relative validity of an FFQ for nutrients in the Tehran lipid and glucose study. Public health nutrition. 13 (5): 654-662.
40. Moran L & Teede H 2009. Metabolic features of the reproductive phenotypes of polycystic ovary syndrome. Human reproduction update. 15 (4): 477-488.
41. Norman R, Dewailly D, Legro R, Hickey T & 370:685–697. L 2007. Polycystic ovary syndrome. Lancet. 9588 (9588): 685-697.
42. Ramezani Tehrani F, Rashidi H, Bahri Khomami M, Tohidi M & Azizi F 2014. The prevalence of metabolic disorders in various phenotypes of polycystic ovary syndrome: a community based study in Southwest of Iran. Reproductive biology and endocrinology. 12 (89): 1-6.
43. Rayman M 2012. Selenium and human health. Lancet. 379 (9822): 1256-1268.
44. Salehpour S 2011. Evaluation of homocysteine levels in patients with polycystic ovarian syndrome. International journal of fertility & sterility. 4 (4): 168.
45. Schorge J, et al. 2008. Williams gynecology. McGraw-Hill Medical: New York.
46. Shishehgar F, et al. 2016. Comparison of dietary intake between polycystic ovary syndrome women and controls. Global journal of health science. 8 (9): 302.
47. Sirmans SM & Pate KA 2014. Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clinical epidemiology. 6: 1-13.
48. Sugiura M, et al. 2006. The homeostasis model assessment-insulin resistance index is inversely associated with serum carotenoids in non-diabetic subjects. Journal of epidemiology. 16 (2): 71-78.
49. Taghdir M, et al. 2009. XML Relationship Between Serum Zinc and Insulin Concentration, Insulin Resistance and Oxidative Stress in Postmenopausal Diabetic Women. Iranian journal of endocrinology and metabolism. 11 (5): 485-596.
50. Teede H, Deeks A & Moran L 2010. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC medicine. 8 (1): 1-10.
51. Thomson RL, Spedding S & Buckley JD 2012. Vitamin D in the aetiology and management of polycystic ovary syndrome. Clinical endocrinology. 77 (3): 343-350.
52. Vincent J 2018. The nutritional biochemistry of chromium (III). Elsevier.
53. Wallace T, Levy J & Matthews D 2004. Use and abuse of HOMA modeling. Diabetes care. 27 (6): 1487-1495.
54. Wang Y, et al. 2017. High dietary selenium intake is associated with less insulin resistance in the Newfoundland population. PloS one. 12 (4): e0174149.
55. Woodside J, McCall D, McGartland C & Young I 2005. Micronutrients: dietary intake v. supplement use. Proceedings of the nutrition society. 64 (4): 543-553.
56. Wright C, Zborowski J, Talbott E, McHugh-Pemu K & Youk A 2004. Dietary intake, physical activity, and obesity in women with polycystic ovary syndrome. International journal of obesity. 28 (8): 1026-1032.
57. Yildizhan R, et al. 2009. Serum 25-hydroxyvitamin D concentrations in obese and non-obese women with polycystic ovary syndrome. Archives of gynecology and obstetrics. 280 (4): 559-563.
58. Ylönen K, et al. 2003. Dietary intakes and plasma concentrations of carotenoids and tocopherols in relation to glucose metabolism in subjects at high risk of type 2 diabetes: the Botnia Dietary Study. American journal of clinical nutrition. 77 (6): 1434-1441.
59. Zeng H 2009. Selenium as an essential micronutrient: roles in cell cycle and apoptosis. Molecules. 14 (3): 1263-1278.
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
